Start for free
Start for free
Sabby Capital logo

Sabby Capital

North America, New Jersey, United States, Upper Saddle River

Description

Sabby Capital is a New Jersey-based investment advisory firm focused on the healthcare industry.

Investor Profile

Sabby Capital has made 12 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (33%)
  • Post Ipo Equity (33%)
  • Series B (25%)
  • Series D (8%)

Country Focus

  • United States (92%)
  • Canada (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Medical
  • Health Diagnostics
  • Oncology
  • Pharmaceutical
  • Hospital
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sabby Capital frequently co-invest with?

venBio Partners
venBio Partners
North America, California, United States, San Francisco
Co-Investments: 3
Ridgeback Capital
Ridgeback Capital
North America, New York, United States, New York
Co-Investments: 2
Wellington Management
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 3
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Rock Springs Capital
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 4
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5
Cowen Group
Cowen Group
North America, New York, United States, New York
Co-Investments: 2
Redmile Group
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 3
Aisling Capital
Aisling Capital
North America, New York, United States, New York
Co-Investments: 2

Which angels does Sabby Capital often collaborate with?

Dan Mendelson
Dan Mendelson
North America, District of Columbia, United States, Washington
Shared Deals: 1

What are some of recent deals done by Sabby Capital?

Epic Sciences

La Jolla, California, United States

Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.

BiotechnologyHealth CareHealth DiagnosticsHospitalPrecision Medicine
Series DApr 28, 2017
Amount Raised: $40,000,000
Ardelyx

Fremont, California, United States

Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

BiotechnologyHealth CareMedical
Post Ipo EquityJun 22, 2015
Amount Raised: $77,771,627
Champions Oncology

Hackensack, New Jersey, United States

Champions Oncology develops advanced technology solutions and services for personalizing the development and use of oncology drugs.

BiotechnologyHealth CareHealth DiagnosticsOncology
Post Ipo EquityMar 12, 2015
Amount Raised: $14,000,000
Cidara Therapeutics

San Diego, California, United States

Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.

BiotechnologyHealth CareTherapeutics
Series BFeb 11, 2015
Amount Raised: $42,000,000
Global Blood Therapeutics

South San Francisco, California, United States

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

BiotechnologyGeneticsMedicalTherapeutics
Series BJan 6, 2015
Amount Raised: $48,000,000
Naurex

Evanston, Illinois, United States

Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.

BiopharmaBiotechnologyTherapeutics
Series CDec 3, 2014
Amount Raised: $80,000,000
Blueprint Medicines

Cambridge, Massachusetts, United States

Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.

BioinformaticsBiotechnologyHealth CareMedical
Series CNov 12, 2014
Amount Raised: $50,000,000
Bellicum Pharmaceuticals

Houston, Texas, United States

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Series CAug 27, 2014
Amount Raised: $55,000,000
Dermira

Menlo Park, California, United States

Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.

BiopharmaBiotechnologyPharmaceutical
Series CAug 19, 2014
Amount Raised: $51,000,000
Adverum Biotechnologies

Menlo Park, California, United States

Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 22, 2014
Amount Raised: $55,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator